Register Of All-Party Parliamentary Groups [as at 19 June 2019] Cancer
Title |
All-Party Parliamentary Group on Cancer |
Purpose |
To keep cancer on the political agenda, monitor implementation of government initiatives, provide briefings to parliamentarians, and ensure policy-making is evidence-based and patient-centred. |
Category |
Subject Group |
Officers |
||
Role |
Name |
Party |
Chair & Registered Contact |
Nic Dakin |
Labour |
Vice-Chair |
Mr John Baron |
Conservative |
Vice-Chair |
Ruth George |
Labour |
Vice-Chair |
Baroness Masham of Ilton |
Crossbench |
Vice-Chair |
Baroness Finlay of Llandaff |
Crossbench |
Vice-Chair |
Baroness Walmsley |
Liberal Democrat |
Vice-Chair |
Baroness Morgan of Drefelin |
Crossbench |
Vice-Chair |
David Tredinnick |
Conservative |
Vice-Chair |
Albert Owen |
Labour |
Vice-Chair |
Mark Pritchard |
Conservative |
Vice-Chair |
Colleen Fletcher |
Labour |
Contact Details |
Registered Contact: Nic Dakin MP, House of Commons, London, SW1A 0AA. Tel: 020 7219 0446. Email: nic.dakin.mp@parliament.uk.
Public Enquiry Point: Olly Parker, Macmillan Cancer Support, 89 Albert Embankment, London SE1 7UQ. Tel: 020 7091 2309. Email: appg@macmillan.org.uk
Secretariat: Macmillan Cancer Support acts as the group's secretariat. http://macmillian.org.uk/
Group's Website:
|
Annual General Meeting |
|
Date of most recent AGM in this Parliament |
29/04/2019 |
Did the group publish an income and expenditure statement relating to the AGM above? |
Yes |
Reporting year |
01 Jan to 31 Dec |
Next reporting deadline |
01/05/2020 |
Registrable benefits received by the group |
|||
Financial Benefits |
|||
Source |
Value £s |
Received |
Registered |
Novartis International |
3,345 |
28/01/2019 |
26/03/2019 |
Reynolds-Mackenzie |
1,745 |
01/11/2018 |
26/03/2019 |
Astra Zeneca UK LT |
2,800 |
30/10/2018 |
26/03/2019 |
Benefits In Kind |
||||
Source |
Description |
Value £s In bands of £1,500 |
Received |
Registered |
Macmillan Cancer Support |
Secretariat
From : 01/01/2019 To : 31/12/2019
|
39,001-40,500 |
01/01/2019 |
30/04/2019 |